Type your tag names separated by a space and hit enter

Age-related macular degeneration (ARMD) – Related resources

Cochrane reviews

  • Interferon alfa-2a appears not to be beneficial for the treatment of age-related macular degeneration and may even have harmful effects [Evidence Level: B].
  • Vitamin E or beta-carotene supplements will not prevent or delay the onset of age-related macular degeneration [Evidence Level: A].
  • There is insufficient evidence on the benefits and harms of steroids with antiangiogenic properties for treating neovascular age-related macular degeneration [Evidence Level: D].
  • Surgical removal of choroidal neovascularisation in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration does not prevent visual loss compared to observation, and the risk of developing cataract and retinal detachment increases after surgery [Evidence Level: A].
  • Laser photocoagulation of drusen appears no to reduce the risk of developing choroidal neovascularisation, geographic atrophy, or visual acuity loss [Evidence Level: B].
  • Statins seem to have no effect on the onset or progression of age-related macular degeneration, although the evidence is insufficient [Evidence Level: D].

Literature

Clinical practice reviews

  • Coleman HR, Chan CC, Ferris FL 3rd, Chew EY. Age-related macular degeneration. Lancet 2008 Nov 22;372(9652):1835-45.  [PMID:19027484]

Other literature

  • Folk JC, Stone EM. Ranibizumab therapy for neovascular age-related macular degeneration. N Engl J Med 2010 Oct 21;363(17):1648-55.  [PMID:20961248]


Copyright © 2017 Duodecim Medical Publications Limited.
Age-related macular degeneration (ARMD) – Related resources is a sample topic from the Evidence-Based Medicine Guidelines.

To view other topics, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Learn more.

Citation

"Age-related Macular Degeneration (ARMD) – Related Resources." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455542/all/Age_related_macular_degeneration__ARMD__–_Related_resources.
Age-related macular degeneration (ARMD) – Related resources. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455542/all/Age_related_macular_degeneration__ARMD__–_Related_resources. Accessed March 23, 2019.
Age-related macular degeneration (ARMD) – Related resources. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/455542/all/Age_related_macular_degeneration__ARMD__–_Related_resources
Age-related Macular Degeneration (ARMD) – Related Resources [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455542/all/Age_related_macular_degeneration__ARMD__–_Related_resources.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Age-related macular degeneration (ARMD) – Related resources ID - 455542 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455542/all/Age_related_macular_degeneration__ARMD__–_Related_resources PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -